Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Halank

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
International Journal of Cardiology|September 8, 2018
General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, et al.
The Lancet. Respiratory Medicine|November 28, 2018
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trialRoela Sadushi-Kolici, Pavel Jansa, Grzegorz Kopec, et al.
International Journal of Molecular Sciences|May 14, 2020
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic StudyChristina A Eichstaedt, Jeremias Verweyen, Michael Halank, et al.
Respiration; International Review of Thoracic Diseases|October 27, 2016
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre TrialEkkehard Grünig, Nicola Benjamin, Tobias J Lange, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Respiratory Research|December 21, 2018
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)Alberto M Marra, Michael Halank, Nicola Benjamin, et al.
The European Respiratory Journal|June 18, 2026
Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertensionRéka Csáki, Vasile Foris, Christina A Eichstaedt, et al.
European Heart Journal|August 2, 2015
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trialNicola Ehlken, Mona Lichtblau, Hans Klose, et al.
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Pulmonary Hypertension Associated with Lung Diseases]Athiththan Yogeswaran, Dirk Skowasch, Vasile Foris, et al.
Pulmonary Circulation|June 9, 2023
Is iron deficiency caused by Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Cardiology|September 8, 2018
General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, et al.
The Lancet. Respiratory Medicine|November 28, 2018
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trialRoela Sadushi-Kolici, Pavel Jansa, Grzegorz Kopec, et al.
International Journal of Molecular Sciences|May 14, 2020
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic StudyChristina A Eichstaedt, Jeremias Verweyen, Michael Halank, et al.
Respiration; International Review of Thoracic Diseases|October 27, 2016
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre TrialEkkehard Grünig, Nicola Benjamin, Tobias J Lange, et al.
The European Respiratory Journal|November 13, 2012
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective surveyStephanie Meyer, Vallerie V McLaughlin, Hans-Juergen Seyfarth, et al.
Respiratory Research|December 21, 2018
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)Alberto M Marra, Michael Halank, Nicola Benjamin, et al.
The European Respiratory Journal|June 18, 2026
Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertensionRéka Csáki, Vasile Foris, Christina A Eichstaedt, et al.
European Heart Journal|August 2, 2015
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trialNicola Ehlken, Mona Lichtblau, Hans Klose, et al.
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Pulmonary Hypertension Associated with Lung Diseases]Athiththan Yogeswaran, Dirk Skowasch, Vasile Foris, et al.
Pulmonary Circulation|June 9, 2023
Is iron deficiency caused by Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, et al.
Pageof 14